Efungumab, a monoclonal antibody exhibiting antifungal properties, specifically targets HSP 90 to inhibit a conformational alteration crucial for fungal survival. It is employed in investigations concerning invasive candidiasis (IC) [1].
CAS Number:
[762260-74-2]
* VAT and and shipping costs not included. Errors and price changes excepted
